WINTON GROUP Ltd decreased its position in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 79.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,822 shares of the health services provider's stock after selling 22,334 shares during the period. WINTON GROUP Ltd's holdings in Universal Health Services were worth $1,045,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Advisors Asset Management Inc. raised its stake in shares of Universal Health Services by 41.8% during the third quarter. Advisors Asset Management Inc. now owns 1,485 shares of the health services provider's stock worth $340,000 after buying an additional 438 shares during the last quarter. Cerity Partners LLC raised its position in shares of Universal Health Services by 86.4% during the 3rd quarter. Cerity Partners LLC now owns 21,047 shares of the health services provider's stock valued at $4,820,000 after acquiring an additional 9,755 shares during the last quarter. Daiwa Securities Group Inc. lifted its stake in shares of Universal Health Services by 13.0% in the 3rd quarter. Daiwa Securities Group Inc. now owns 7,340 shares of the health services provider's stock valued at $1,681,000 after purchasing an additional 843 shares during the period. Fisher Asset Management LLC acquired a new stake in shares of Universal Health Services during the third quarter worth $543,000. Finally, BNP Paribas Financial Markets increased its holdings in Universal Health Services by 12.6% in the third quarter. BNP Paribas Financial Markets now owns 145,259 shares of the health services provider's stock valued at $33,266,000 after purchasing an additional 16,199 shares during the last quarter. 86.05% of the stock is currently owned by institutional investors and hedge funds.
Universal Health Services Stock Up 0.5 %
Shares of UHS stock traded up $0.86 during trading on Wednesday, reaching $188.67. The company's stock had a trading volume of 117,047 shares, compared to its average volume of 733,532. Universal Health Services, Inc. has a one year low of $152.69 and a one year high of $243.25. The business has a fifty day moving average price of $181.95 and a 200-day moving average price of $196.34. The company has a market cap of $12.26 billion, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 0.53 and a beta of 1.32. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69.
Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported $4.92 EPS for the quarter, topping the consensus estimate of $4.21 by $0.71. The firm had revenue of $4.11 billion for the quarter, compared to analysts' expectations of $4.01 billion. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. Analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.
Universal Health Services Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend was Monday, March 3rd. Universal Health Services's dividend payout ratio (DPR) is 4.75%.
Analyst Upgrades and Downgrades
UHS has been the topic of a number of recent analyst reports. Barclays reduced their target price on Universal Health Services from $271.00 to $249.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group cut shares of Universal Health Services from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $228.00 to $198.00 in a report on Monday, December 16th. Stephens lifted their price target on shares of Universal Health Services from $210.00 to $223.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Cantor Fitzgerald upgraded shares of Universal Health Services from a "neutral" rating to an "overweight" rating in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $226.00 price objective on shares of Universal Health Services in a research note on Tuesday, December 17th. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $228.38.
Read Our Latest Stock Report on UHS
Insider Transactions at Universal Health Services
In other news, Director Maria Ruderman Singer sold 1,000 shares of the company's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $179.16, for a total value of $179,160.00. Following the sale, the director now directly owns 7,916 shares of the company's stock, valued at approximately $1,418,230.56. This represents a 11.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 16.10% of the company's stock.
About Universal Health Services
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Featured Stories

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.